Mr Jay Lefkowitz > Kirkland & Ellis LLP > New York, United States > Lawyer Profile
Kirkland & Ellis LLP Offices

601 LEXINGTON AVENUE
NEW YORK, NY 10022
NEW YORK
United States
- Firm Profile
- Go to...
Mr Jay Lefkowitz

Position
Jay Lefkowitz is a litigation partner at Kirkland. He is also an adjunct professor at Columbia Law School, where he teaches a seminar on Supreme Court advocacy. Jay has served as lead trial and appellate counsel in a wide variety of substantive areas, including shareholder disputes, antitrust, product liability, litigation against the FDA and False Claims Act matters. He has also conducted numerous internal investigations for public companies and audit committees.
In its 2013 release of “The 100 Most Influential Lawyers in America,” The National Law Journal describes Jay as “a leading voice on school choice issues” and “a no-nonsense appellate and antitrust lawyer for an array of blue-chip clients.” The Legal 500 U.S. noted that Jay “provides a depth of understanding and influence in some of the highest courts of our country,” and in Chambers USA, America’s Leading Lawyers for Business, clients say, “‘Jay is brilliant; there is no other way to put it.’” Jay was also named a Law360 “MVP of the Year” in 2011 for his Appellate practice, and in 2012, 2013, 2014, 2015 and 2016 for his Life Sciences work. Jay is one of only three of the 189 MVPs named to the list six years in a row. The American Lawyer named him its “Lawyer of the Week” in December 2012 for his role in winning an antitrust lawsuit in the pharmaceutical industry.
Lawyer Rankings
United States > Healthcare > Life sciences
(Leading partners)Kirkland & Ellis LLP advises established global and developing companies, as well as private equity and venture capital investors, on litigation and corporate matters. Renowned for its deep litigation bench, the firm represents clients in product liability, antitrust, patent and commercial matters. Key figures include trial and appellate lawyer New York-based Jay Lefkowitz and Chicago’s James Hurst, a trial lawyer focused on IP and commercial litigation. Both in New York, Devora Allon specializes in product liability, antitrust, and commercial litigation in NY, whereas Jeanna Wacker concentrates on IP. On the corporate side, the practice has experience structuring deals and navigating transaction-related regulatory matters, with New York-based Dennis Williams bringing valuable expertise in regulatory on the latter. Boston-based Graham Robinson joined the firm in mid-2025, bringing significant transactional and governance expertise.
United States > Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
Lauded by one client as ‘outstanding across the board’, the team of ‘excellent strategic thinkers’ at Kirkland & Ellis LLP draws on notable experience briefing and arguing cases in the federal courts of appeals, state appellate courts, and the Supreme Court of the United States. The team has significant expertise in appeals involving antitrust, bankruptcy, class action, IP, trade secrets, environmental, and professional liability matters. Washington, D.C.-based John O’Quinn, who is praised as a ‘keen legal thinker, amazing writer … and responsive and clear with client communications’, steers the practice and majors on IP disputes, regulatory matters, and commercial litigation at the trial and appellate levels. Also noted in D.C. are George Hicks and Jason Wilcox. A key contact in New York, Jay Lefkowitz recently represented Gilead Sciences, Inc. in antitrust class action litigation related to the development and sale of HIV treatments.
Lawyer Rankings
- Leading partners United States > Healthcare > Life sciences
- Appellate: courts of appeals / Appellate: supreme courts (states and federal) United States > Dispute resolution
- Life sciences United States > Healthcare
Top Tier Firm Rankings
- Media, technology and telecoms > Advertising and marketing: litigation
- Finance > Capital markets: high-yield debt offerings
- International trade and national security > CFIUS
- Antitrust > Civil litigation/class actions: defense
- Finance > Commercial lending
- Intellectual property > Copyright
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Energy > Energy litigation: oil and gas
- Energy > Energy transactions: electric power
- Energy > Energy transactions: oil and gas
- Environment > Environment: transactional
- Dispute resolution > General commercial disputes
- Tax > International tax
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: litigation (full coverage)
- Intellectual property > Patents: litigation (International Trade Commission)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Real estate > Real estate
- Energy > Renewable/alternative power
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Securities litigation: defense
- M&A/corporate and commercial > Shareholder activism
- Finance > Structured finance: securitization
- Media, technology and telecoms > Technology transactions
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Intellectual property > Trademarks: litigation
- Tax > US taxes: non-contentious
Firm Rankings
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Antitrust > Cartel
- Dispute resolution > E-discovery
- Energy > Energy regulation: electric power
- Antitrust > Merger control
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Media, technology and telecoms > Outsourcing
- Intellectual property > Patents: licensing
- Dispute resolution > Product liability, mass tort and class action - defense: automotive/transport
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Real estate > Real estate investment trusts (REITs)
- Government > State attorneys general
- Tax > US taxes: contentious
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Transport > Aviation and air travel: litigation and regulation
- Finance > Commercial lending > Advice to direct lenders/private credit
- M&A/corporate and commercial > Corporate governance
- Environment > Environment: litigation
- Dispute resolution > Financial services litigation
- Insurance > Insurance: non-contentious
- Media, technology and telecoms > Media and entertainment: litigation
- Media, technology and telecoms > Media and entertainment: transactional
- International trade and national security > National Security
- Finance > Project finance
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- International trade and national security > Customs, export controls and economic sanctions
- Healthcare > Life sciences
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Government > Government relations